Predicting Residual Cancer Burden In A Triple Negative Breast Cancer Cohort

Analysis and interpretation of stained histopathology sections is one of the main tools in cancer diagnosis and prognosis. In addition to the information which is typically extracted by trained pathologists, there is also information that is not yet exploited, simply because we do not yet understand the impact of all cellular and tissular features that could be predictive of outcome. In this paper, we address a question that can currently not be solved by pathologists: the prediction of treatment efficiency for Triple Negative Breast Cancer (TNBC) patients from biopsy data.